 |
|
Ethical Issues in Governing Biobanks: Global Perspectives
By Bernice Elger, Nikola Biller-Andorno, Alexandre Mauron, and Alexander M. Capron
257 pp, $114.95
Farnham, UK, Ashgate Publishing, 2008
ISBN-13: 978-0-7546-7255-5
JAMA. 2009;301(24):2596-2597.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Many nations are now establishing large population-based biobanks and associated human genetic research databases that combine genetic information derived from biological samples with personal data about environment, medical history, lifestyle, or genealogy. Notable examples in addition to the pioneering Icelandic Health Sector Database Project are the Karolinska Institutet (Sweden), CARTaGENE (Canada), National Heart, Lung, and Blood Institute (National Institutes of Health, United States), KORA-GEN (Germany), the Western Australian Genome Health Project (Australia), and the Centre for Integrated Genomic Medical Research (United Kingdom). There have been few texts dedicated to the regulatory issues posed by biobanks. The most obvious comparitor is Biobanks Governance in Comparative Perspective (2008, Routledge), edited by Herbert Gottweis and Alan Petersen, which focuses more on issues associated with establishing biobanks in particular countries in Europe, the United States, and Australia.
Ethical Issues in Governing Biobanks arose from a collaborative research project between the World Health Organization Department . . . [Full Text of this Article]
Thomas A. Faunce, LLB, BMed, PhD, Reviewer
Medical School and College of Law
Australian National University
Canberra, Australia
thomas.faunce@anu.edu.au
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
